Anonymous
Guest
Anonymous
Guest
What if the FDA knew about our regional meetings and being required to do role play on a study that is dissemination only??????? How does Abbott get away with some of the things they do???
what reprint are we being required to
do role play that isn't for promotion? I haven't heard this
anyone that uses that reprint other than dissemination only is an idiot, especially during these upcoming meetings,
I just want to know what the FDA would do if they knew.
What would you like the FDA to do? They can't do anything. It's your meeting, and if management expects you to know and articulate the contents of the study, so what? As long as you don't discuss it in the field with a HCP, it's none of the FDA's business.
What would you like the FDA to do? They can't do anything. It's your meeting, and if management expects you to know and articulate the contents of the study, so what? As long as you don't discuss it in the field with a HCP, it's none of the FDA's business.
The FDA knows that we are still actively promoting two drugs that have not only done nothing to advance patient care in two NIH studies but have also caused harm to specific groups within those studies! At bare minimum our circulars should contain warnings against using fibrates or niacin in any diabetics, elderly & women specifically and yet we've done nothing to tell physicians and continue to prevaricate and drag our heels! My manager told us to stay away from any information on ACCORD or AIM-HIGH until those studies are confirmed..which they'll never be until the drugs are off patent and will mean nothing to our bottom line!
There is certainly a very strong suggestion that they are encouraging and condoning that we use off label and unauthorized material with doctors by drilling us on them.
That is not a big leap of faith. Not appropriate at all.
What would you like the FDA to do? They can't do anything. It's your meeting, and if management expects you to know and articulate the contents of the study, so what? As long as you don't discuss it in the field with a HCP, it's none of the FDA's business.
Spoken like a true Ab BOTT manager
Not an Abbott manager. Not even employed by ABT. Was laid off in January and still check this site to see what's happening there. But what's the big deal about this? If you're so concerned about what the FDA would do, TELL them! Then you'll know they won't do anything. It's a gov't institution, they don't move their asses unless they have to.
If your concern is that you are being railroaded by management to sell off label, TELL THEM! Tell them you won't do it. What the hell, in six months most of you in dyslipidemia will be gone anyway.
If this is one of those BS "Four square" exercises, don't pick that reprint to detail from. If you are made to use it, role-play it, "Doc, I'm leaving this reprint for your review, if you have any questions, call Med Info."
Don't you know yet how to play this stupid game?
I repeat, as long as you don't actually discuss this reprint with a HCP, the FDA can't/won't do anything.